Does Trigeminal Nerve Stimulation Work for ADHD?

"A medication-free device, worn on the forehead, that works while you sleep." For the family of a child with ADHD, this sentence sounds almost too good. That the device has also received official approval adds to its credibility.

I briefly described this device, external trigeminal nerve stimulation (TNS), in the post on lesser-known methods in ADHD. In that post I wrote that in a large trial it did not come out different from the sham device. Now I am reporting that trial in a separate post, with the details in its abstract.

Who the study is from and where

The study was published in the journal Nature Medicine in 2026 (volume 32, issue 2, pages 582-590). The publication date in Nature's record is 16 January 2026. The first author is Aldo Alberto Conti, and among the last authors are Samuele Cortese and Katya Rubia, with seventeen authors in all. The abstract does not mention the authors' institutions.

The study is a randomized, double-blind, sham-controlled, parallel-group, multicenter trial. Each of these is a separate safeguard. Randomized means that which group the children go to is decided by lot. Double-blind means that neither the child nor the assessor knows who is wearing the real device. A sham device is a control device that looks like the real one but is set differently: this way the expectation "I'm wearing something, I'll get better" is equalized in the two groups. Parallel-group means that the two groups are followed at the same time, separately. The abstract calls the study "phase 2b" and describes it as a confirmatory study. The trial is registered under the number ISRCTN82129325.

150 children and teens in total were included in the study. 75 went into the real TNS group and 75 into the sham TNS group. The mean age in both groups was 12.6 years, with a standard deviation of 2.8 (the standard deviation is a number showing how widely the ages spread around the mean). The abstract does not give the girl-boy ratio or the inclusion criteria.

This post is a Turkish-language summary of the paper published open access in Nature Medicine. The paper was published under the Creative Commons Attribution 4.0 (CC BY 4.0) license. The findings belong to the authors of the paper; the account and appraisal here are mine. All I have is the abstract of the paper, and every number I write comes from there.

Why this trial was done

The first sentence of the abstract is the answer to this question. TNS received clearance from the U.S. Food and Drug Administration (FDA) in 2019 and was cited as the first device-based, non-drug treatment for ADHD. The clearance rested on a small, sham-controlled pilot study with 62 children with ADHD. That study had reported an improvement in symptoms.

Pilot studies are good for looking at whether an idea is promising, but the results of small studies often shrink in a large study. So the real question was this: does this effect also appear in a larger, more rigorous trial? This study tests exactly that.

What was done

The children wore the device for about nine hours every night for four weeks. The real TNS works on both sides and, with battery-powered electrodes placed on the forehead, targets the V1 branches of the trigeminal nerve. The sham TNS, on the other hand, gives stimulation for only 30 seconds per hour, and does so with a lower frequency and pulse width. So the sham device also really does something, but markedly less than the real device, and something different.

The study aims to look at both short-term and long-term (six-month) effects. However, the abstract does not give the six-month results separately. The only result with a number in the abstract is the primary outcome, ADHD symptoms. For the six-month findings you need to look at the full text; I could not see that part.

Findings

The analysis was done according to the "intention-to-treat" principle. This means that everyone assigned by lot to a group is counted within that group, regardless of how long they kept up the treatment. This approach makes it harder to show the result as better than it is.

The result: there is no significant difference between real and sham TNS in ADHD symptoms. The adjusted mean difference is 0.83. The 95 percent confidence interval is between minus 2.47 and 4.13, the P value is 0.622, and Cohen's d is 0.09.

Let me explain them in order. The adjusted mean difference is the difference in symptom score between the two groups. The abstract does not say which scale the score comes from or who filled it in, so I cannot interpret from here how much 0.83 is clinically. The confidence interval is the range in which the true difference can plausibly be found. The interval includes zero: that is, the difference could be zero, could be slightly positive, could be slightly negative. The P value is 0.622. The P value says that even if there were no difference at all in reality, seeing a difference this large would not be surprising at all. The usual threshold is 0.05, so 0.622 is very far from it. Cohen's d is the effect size, which expresses the difference relative to the spread of the data. In common usage 0.2 is counted as small. 0.09 is below even that.

On the safety side: no serious side effects were reported, and side effects did not differ between the groups. The authors tie the result together like this: TNS is a safe intervention, but it does not show clinical efficacy for pediatric ADHD.

What this finding means for me

If you are considering this device or have used it before, the message from the abstract is this: in this trial, the device giving a real stimulus did not bring a better symptom outcome than the sham stimulus. This does not mean that those who used the device could not feel an improvement. Something may also have changed in the sham group. The abstract does not give the change within groups, only the difference between groups. Expectation, change that comes by itself over time, or the effect of other treatments can explain this change.

A side consequence of this is: the experience of individual families, "it worked for us", can be real and still not come from the device. The way to tell these apart is sham-controlled trials, and this is one of them.

The safety finding is valuable too. The device did not cause serious harm in this study. So this is not a "dangerous but it doesn't work" story, it is a "does no harm but did not show the expected benefit" story.

What this finding does not say

The study tested a single protocol: four weeks, throughout the night, a particular device setting. Whether the result would be the same for another duration, another intensity or another age group is not known from this abstract. Saying "no TNS protocol works" would be more than this trial can say.

The average effect being close to zero does not rule out individual differences. The abstract does not offer a breakdown by subgroups of children.

The ends of the interval also need attention. What clinical meaning the interval of minus 2.47 to 4.13 has cannot be read from the abstract, since the scale is not known. So instead of "definitely zero", saying "a significant benefit could not be shown" is more accurate. The authors' own sentence is also this: it could not show clinical efficacy.

Also, this post is not a treatment recommendation. What is suitable for your child's ADHD treatment is something to choose together with the doctor who evaluates them. I collected the options that have evidence in the post medication or therapy in ADHD. If you are looking for a non-drug method, there is a similar question for neurofeedback, and you can find it in the neurofeedback post.

What I take from it

What this trial taught me is that the sentences "it got clearance" and "it has been shown to work" are not the same thing. The device received clearance after a small study, made the news, families were curious. When the large sham-controlled trial came, there was no significant difference left.

I do not think this is bad news. This is exactly how science works: a promising idea, then a trial that pushes on it. The hard part is that the first excitement is heard loudly, while the correction comes much more quietly. I suggest that with every piece of praise you read about a device or method, you ask how many people the study behind it had and what it was compared with.

If it were me, while looking for a medication-free option for my child, before spending money on this kind of device I would make room for behavioral programs with firmer evidence and for the conversation with the doctor.